


FBX-101 and the RESKUE Trial: Exploring AAV-Based Gene Therapies for Krabbe Disease









When Laboratory and Workplace Design Converge









Dr. Timothy J. Miller on building Ohio’s biotech hub and manufacturing gene therapies for life









Women of Influence: Erandi de Silva, Forge Biologics









No Disease is Safe with Dr. Tim Miller, Forge Biologics









CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller









Forging Gene Therapy Capacity and a Pipeline at the Same Time








